Literature DB >> 28748586

Legal termination of pregnancy as an opportunity for expanding postabortion contraception: Experience at the Pereira Rossell Hospital, Montevideo, Uruguay.

Fernanda Nozar1, Diego Greif1, Francisco Coppola1, Verónica Fiol1, Leonel Briozzo1.   

Abstract

OBJECTIVE: To determine to what extent women adopted highly effective contraceptive methods after a legal abortion.
METHODS: The data available during a period before and another period after liberalization of the abortion law were reviewed. The data gathering was incomplete and reliable only during certain periods, which were used in the study.
RESULTS: There was an increase in the proportion of women who returned for contraception and in the proportion who used any method and long-acting methods; however, no contraception was administered immediately after abortion and only 16% of all women treated started to use a long-acting method during the period after the law was liberalized.
CONCLUSION: The proposed objective was not being achieved, the recommended guidelines were not being followed, and data gathering was incomplete. Good intentions are not enough and it is always necessary to evaluate the performance of a program. The results indicate that immediate reforms are necessary in postabortion contraception services.
© 2016 The Authors. Published by International Federation of Gynecology and Obstetrics and John Wiley & Sons Ltd.

Entities:  

Keywords:  Data quality; Legal abortion; Long-acting reversible contraceptives; Postabortion contraception; Uruguay

Mesh:

Year:  2016        PMID: 28748586     DOI: 10.1016/j.ijgo.2016.06.009

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Experience obtaining legal abortion in Uruguay: knowledge, attitudes, and stigma among abortion clients.

Authors:  Shelly Makleff; Ana Labandera; Fernanda Chiribao; Jennifer Friedman; Roosbelinda Cardenas; Eleuthera Sa; Sarah E Baum
Journal:  BMC Womens Health       Date:  2019-12-09       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.